SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-119329
Filing Date
2024-11-14
Accepted
2024-11-14 17:49:30
Documents
1
Group Members
LENE SKOLE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427620d14_sc13ga.htm SC 13G/A 60542
  Complete submission text file 0001104659-24-119329.txt   62111
Mailing Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100
Business Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100 4540307375
Lundbeckfond Invest A/S (Filed by) CIK: 0001591046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94231 | Film No.: 241464780
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)